Literature DB >> 34386912

UV Light-Activated GdYVO4:Eu3+ Nanoparticles Induce Reactive Oxygen Species Generation in Leukocytes Without Affecting Erythrocytes In Vitro.

Anatolii Onishchenko1,2, Valeriy Myasoedov3, Svetlana Yefimova4, Oksana Nakonechna2, Volodymyr Prokopyuk1,5, Dmytro Butov6, Umut Kökbaş7, Vladimir Klochkov4, Pavel Maksimchuk4, Nataliya Kavok4, Anton Tkachenko8,9.   

Abstract

Nanoparticles (NPs) have been reported to be promising enhancement agents for radiation therapy. The aim of the study was to assess the cytotoxicity of UV non-treated and UV pretreated GdYVO4:Eu3+ nanoparticles against erythrocytes and leukocytes by detecting eryptosis and reactive oxygen species (ROS) generation. Levels of intracellular ROS in erythrocytes and leukocytes using a ROS-sensitive dye 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA), as well as eryptosis rate utilizing annexin V staining, following direct exposure to UV-activated and nonactivated NPs were detected by flow cytometry. Blood cells were collected from 9 intact WAG rats. Neither the UV light-untreated GdYVO4:Eu3+ NPs nor the treated ones promoted eryptosis and ROS generation in erythrocytes. Low concentrations of UV light-untreated NPs did not induce oxidative stress in leukocytes, evidenced by unaffected intracellular ROS levels. UV light treatment grants prooxidant properties to NPs, confirmed by NP-induced ROS overproduction in leukocytes. High concentrations of both UV light-treated and untreated NPs altered the redox state of leukocytes. UV light treatment imparts prooxidant properties to GdYVO4:Eu3+ NPs, making them promising radiosensitizing agents in cancer radiation therapy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  2ʹ,7ʹ-dichlorodihydrofluorescein diacetate; Annexin V; Eryptosis; Flow cytometry; Nanomaterials; Oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 34386912     DOI: 10.1007/s12011-021-02867-z

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  35 in total

1.  Targeted nanoparticles for tumour radiotherapy enhancement-the long dawn of a golden era?

Authors:  Elisabetta Gargioni; Florian Schulz; Annette Raabe; Susanne Burdak-Rothkamm; Thorsten Rieckmann; Kai Rothkamm
Journal:  Ann Transl Med       Date:  2016-12

2.  The global cancer burden: necessity is the mother of prevention.

Authors:  Christopher P Wild
Journal:  Nat Rev Cancer       Date:  2019-03       Impact factor: 60.716

Review 3.  Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer.

Authors:  Dnyaneshwar Kalyane; Nidhi Raval; Rahul Maheshwari; Vishakha Tambe; Kiran Kalia; Rakesh K Tekade
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-01-18       Impact factor: 7.328

4.  Synergetic Influence of Bismuth Oxide Nanoparticles, Cisplatin and Baicalein-Rich Fraction on Reactive Oxygen Species Generation and Radiosensitization Effects for Clinical Radiotherapy Beams.

Authors:  Noor Nabilah Talik Sisin; Khairunisak Abdul Razak; Safri Zainal Abidin; Nor Fazila Che Mat; Reduan Abdullah; Raizulnasuha Ab Rashid; Muhammad Afiq Khairil Anuar; Wan Nordiana Rahman
Journal:  Int J Nanomedicine       Date:  2020-10-12

5.  How chemotherapy and radiotherapy damage the tissue: Comparative biology lessons from feather and hair models.

Authors:  QingXiang Gao; GuiXuan Zhou; Sung-Jan Lin; Ralf Paus; ZhiCao Yue
Journal:  Exp Dermatol       Date:  2018-12-21       Impact factor: 3.960

6.  Normal tissue protection for improving radiotherapy: Where are the Gaps?

Authors:  Pataje G S Prasanna; Helen B Stone; Rosemary S Wong; Jacek Capala; Eric J Bernhard; Bhadrasain Vikram; C N Coleman
Journal:  Transl Cancer Res       Date:  2012-06       Impact factor: 1.241

Review 7.  Nanoparticles for Radiation Therapy Enhancement: the Key Parameters.

Authors:  Paul Retif; Sophie Pinel; Magali Toussaint; Céline Frochot; Rima Chouikrat; Thierry Bastogne; Muriel Barberi-Heyob
Journal:  Theranostics       Date:  2015-06-11       Impact factor: 11.556

Review 8.  Recent advances in radiation oncology.

Authors:  Cristina Garibaldi; Barbara Alicja Jereczek-Fossa; Giulia Marvaso; Samantha Dicuonzo; Damaris Patricia Rojas; Federica Cattani; Anna Starzyńska; Delia Ciardo; Alessia Surgo; Maria Cristina Leonardi; Rosalinda Ricotti
Journal:  Ecancermedicalscience       Date:  2017-11-30

9.  The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.

Authors:  Taifeng Du; Jiefeng Xiao; Zhaolong Qiu; Kusheng Wu
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

Review 10.  Improving radiotherapy in cancer treatment: Promises and challenges.

Authors:  Helen H W Chen; Macus Tien Kuo
Journal:  Oncotarget       Date:  2017-06-08
View more
  3 in total

1.  Antimicrobial Effects of Nanostructured Rare-Earth-Based Orthovanadates.

Authors:  Serpil Gonca; Svetlana Yefimova; Nadir Dizge; Anton Tkachenko; Sadin Özdemir; Volodymyr Prokopiuk; Vladimir Klochkov; Nataliya Kavok; Anatolii Onishchenko; Pavel Maksimchuk; Dmytro Butov; Kasim Ocakoglu
Journal:  Curr Microbiol       Date:  2022-07-14       Impact factor: 2.343

2.  Assessing the Cytotoxicity of TiO2-x Nanoparticles with a Different Ti3+(Ti2+)/Ti4+ Ratio.

Authors:  Volodymyr Prokopiuk; Svetlana Yefimova; Anatolii Onishchenko; Valeriy Kapustnik; Valeriy Myasoedov; Pavel Maksimchuk; Dmytro Butov; Irina Bespalova; Anton Tkachenko
Journal:  Biol Trace Elem Res       Date:  2022-08-27       Impact factor: 4.081

3.  Cytotoxicity of Hybrid Noble Metal-Polymer Composites.

Authors:  Anton Tkachenko; Pavlo Virych; Valeriy Myasoyedov; Volodymyr Prokopiuk; Anatolii Onishchenko; Dmytro Butov; Yuliia Kuziv; Oleg Yeshchenko; Sican Zhong; Guochao Nie; Nataliya Kutsevol
Journal:  Biomed Res Int       Date:  2022-10-11       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.